Herbal combination (Boswellia, turmeric, grape extract) for hip or knee osteoarthritis
Official title: Effectiveness of a Herbal Supplement Containing Boswellia Serrata, Curcuma Longa, and Vitis Vinifera in Patients With Osteoarthritis.
Run by Middlesex University · NCT07324746 · Data updated 2026-11-12
This study will test whether a daily herbal supplement containing Boswellia serrata, turmeric (curcumin), and grape extract (Vitis vinifera) reduces pain and improves function in adults with hip or knee osteoarthritis.
Quick facts
| Study type | Interventional |
|---|---|
| Ages | 18 Years and up |
| Sex | All |
| Enrollment | 30 (estimated) |
| Sponsor | Middlesex University Academic / other |
| Locations | 1 site (London) |
| Status | Recruiting |
| Started | December 5, 2025 |
| Main results expected | September 2026 |
| Study ends | September 2026 |
| Registry record updated | January 29, 2026 |
| Trial ID | NCT07324746 on ClinicalTrials.gov |
Is this trial a fit for you?
✓Likely a good fit
Adults aged 18 and over with clinically diagnosed knee or hip osteoarthritis, moderate pain (NRS ≥4) and a Lequesne Functional Index ≥7 who can attend the London site and complete online assessments.
✕Probably not a fit
People who are pregnant or breastfeeding, have autoimmune joint disease, recent intra-articular or systemic corticosteroid use, severe joint injury or complete cartilage loss, significant liver or kidney dysfunction, or known allergy to the supplement ingredients are unlikely to benefit or be eligible.
A plain-English reading of the study's rules. Only the study team can confirm whether you qualify.
What this trial studies
This is a randomized, placebo-controlled crossover trial in which adults with clinically diagnosed hip or knee osteoarthritis will take the active herbal supplement for four weeks and a matching placebo for four weeks, one after the other. Participants will complete validated symptom questionnaires and three performance-based physical tests six times in total and will provide a urine sample for safety or compliance checks. Eligible participants must have moderate pain (NRS ≥4) and functional impairment (Lequesne Index ≥7); people with autoimmune disease, recent steroid injections, severe joint damage, pregnancy, or abnormal liver/kidney function are excluded. The primary comparison is symptom change between the supplement and placebo periods.
Why it matters
Potential benefit: If effective, the herbal combination could reduce pain and improve mobility for people with knee or hip osteoarthritis, offering a non-prescription alternative to standard pain medications.
How similar studies have gone: Multiple small randomized trials and meta-analyses have reported modest symptom improvements with curcumin and Boswellia formulations in osteoarthritis, but larger, rigorously controlled studies are still limited.
Who can join: the full rules
Show full inclusion / exclusion criteria
Inclusion Criteria: * Aged ≥ 18 * Diagnosis of osteoarthritis in knee or hip * Numerical Rating Scale (NRS) ≥ 4 during the most painful movement in the last 24 hours * Lequesne's Functional Index (LFI) score ≥ 7 * Ambulant patient Exclusion Criteria: * Pregnant and breastfeeding * Autoimmune disease such as rheumatoid arthritis, gout, lupus * Joint trauma, joint injury, joint infection, meniscus tear, complete loss of articular cartilage * Expectation of surgery * History of the viscous or corticosteroids injections into affected joints or oral corticosteroids within last 12 months * Allergy to one of the intervention's ingredients or NSAIDs * Peptic ulceration and upper gastrointestinal haemorrhage * High alcohol intake, inability to abstain from alcohol, substance abuse, history of addiction * Tumor, cancer * Abnormal renal or/and hepatic functions or altered blood chemistry * Use of concomitant medication able to interfere with the interventions
Where it's running
-
Middlesex Univeristy London
London, United Kingdom Recruiting
Study contacts
- Study coordinator: Patrycja Brodka Pedrp, MSc
- Email: p.x.brodkapedro@mdx.ac.uk
- Phone: 020-8411-2721
Similar studies
Other studies for the same condition or treatment. Recruiting studies are listed first.
-
Choose to Move Replacement Ready for OA patients waiting for hip or knee replacement
This program tests a tailored, online version of a 3-month activity and social-connection plan for older adults with hip or knee osteoarthritis who are waiting for joint replacement surgery to see if it improves physical activity and health while they wait.
-
Platelet-rich plasma injections for joint and tendon problems
This project will test whether platelet-rich plasma (PRP) injections help people with osteoarthritis and other musculoskeletal conditions reduce pain and improve function over one year.
-
Using glucocorticoids to relieve acute osteoarthritis pain in the emergency department
This study is testing if adding glucocorticoids to regular pain medications can help adults with sudden osteoarthritis pain feel better in the emergency department.
-
Medial knee osteoarthritis: inside vs outside corticosteroid injection
This study tests whether injecting a steroid inside the knee joint leads to different pain results than injecting it on the outside of the knee in people with medial knee osteoarthritis.
-
Can robotic-assisted knee replacement with functional alignment improve outcomes vs. standard knee replacement?
This trial tests whether using the VELYS robotic system during total knee replacement helps patients with knee osteoarthritis feel better and move more comfortably compared with conventional non-robotic surgery.
-
Post-Operative Pain Relief with Zynrelef vs Periarticular Injections in Robot-Assisted Knee Replacement
This study tests whether the Zynrelef extended-release periarticular injection can reduce pain and opioid use after robot-assisted total knee arthroplasty compared with standard periarticular injections.
How to take part
- Review the eligibility criteria above with your treating physician.
- Check the official listing on ClinicalTrials.gov for the latest contact details and recruitment status.
- Contact the study coordinator or principal investigator to ask for pre-screening. Pre-screening is free and never obligates you to enroll.